Russia registers ‘world’s first’ nasal version of COVID vaccine

News agency TASS said in January that the nasal version would be available in Russia in three to four months

Representative photo: iStock

Russia’s health ministry has registered its first – and the world’s first – nasal version of COVID-19 vaccine.

News agency TASS said in January that the nasal version would be available in Russia in three to four months. It quoted Alexander Gintsburg, the director of the Gamaleya Centre, a research institute that manufactures Sputnik V.

The second phase of clinical trials was authorised by the ministry back in October 2021.

Gintsburg told TASS that laboratory tests of Sputnik V had shown protection against Omicron in its injection form and would also be effective in the nasal form.

Advertisement



In India, Sputnik V was first administered in Hyderabad in May 2021. The first consignment of the vaccine had landed on May 1 and went on to receive regulatory clearance on May 13, 2021, from the Central Drugs Laboratory.

CATCH US ON: